Sibanda OS. Comparative analysis of access to patented HIV/AIDS pharmaceutical medicines through the Canadian and EU TRIPS flexibilities measures: are they efficacious or overly burdensome and ineffective measures?. PER [Internet]. 2017 May 25 [cited 2024 Nov. 26];15(2):520-52. Available from: https://perjournal.co.za/article/view/2498